Pharmacokinetics of oxypolygelatine in healthy volunteers |
| |
Authors: | P. A. Thürmann R. Lissner W. G. Struff S. Harder |
| |
Affiliation: | (1) Philipp Klee Institute of Clinical Pharmacology, Klinikum Wuppertal GmbH, Arrenberger Strasse 20, D-42117 Wuppertal, Germany e-mail: Petra.Thuermann@klinikum-wuppertal.de Tel.: +49-202-394-5600, Fax: +49-202-394-5602, DE;(2) Biotest Pharma, Dreieich, Germany, DE;(3) Institute of Clinical Pharmacology, Johann Wolfgang Goethe University, Frankfurt am main, Germany, DE |
| |
Abstract: | Objective/methods: The pharmacokinetics of the plasma substitute oxypolygelatine (OPG) were studied in 12 healthy volunteers after single-dose administration of 27 ml · kg−1 body weight, with a maximum of 2000 ml. OPG was determined in plasma and urine over 48 h after the infusion. Peak plasma OPG concentrations at the end of the infusion were determined to 4.600 (623) μg · ml−1, the area under the plasma concentration/time curve (AUC0∞) was calculated to 70.135 (15.861) μg · h · ml−1. Results: The model-independently calculated volume of distribution came to 23.1 (4.8) l with a clearance total is (Cltot) of 24.6 (6.8) ml · min−1. The initial half-life according to a three-compartment model came to 0.3 (0.2) h, followed by a distribution half-life of 3.1 (2.6) h and a terminal elimination half-life of 13.4 (2.2) h. Cumulative urinary excretion of OPG was 64% after 48 h. Conclusion: This low recovery rate may be explained by the distribution of OPG into the extravascular space and subsequent degradation in tissue sites. Received: 9 June 1998 / Accepted in revised form: 23 November 1998 |
| |
Keywords: | Oxypolygelatine Pharmacokinetics Healthy volunteers Tolerability |
本文献已被 PubMed SpringerLink 等数据库收录! |
|